2024 |
Y-Mabs Therapeutics Inc
|
Independent Director |
- |
- |
2024 |
Jazz Pharmaceuticals plc
|
Independent Director |
- |
- |
2023 |
AnaptysBio Inc
|
Independent Director |
283.1 K |
10.8 % |
2023 |
Y-Mabs Therapeutics Inc
|
Independent Director |
168.1 K |
-25.4 % |
2023 |
Scilex Holding Company - Warrants (10/11/2027)
|
Independent Director |
- |
- |
2023 |
Jazz Pharmaceuticals plc
|
Independent Director |
- |
- |
2023 |
Scilex Holding Company
|
Independent Director |
- |
- |
2022 |
AnaptysBio Inc
|
Independent Director |
255.6 K |
-12.6 % |
2022 |
Y-Mabs Therapeutics Inc
|
Independent Director |
225.3 K |
-47.5 % |
2022 |
Scilex Holding Company - Warrants (10/11/2027)
|
Independent Director |
67.6 K |
- |
2022 |
Scilex Holding Company
|
Independent Director |
67.6 K |
- |
2021 |
Y-Mabs Therapeutics Inc
|
Independent Director |
429.1 K |
-50.5 % |
2021 |
AnaptysBio Inc
|
Independent Director |
292.6 K |
59.7 % |
2021 |
Scilex Holding Company
|
Independent Director |
- |
- |
2020 |
Y-Mabs Therapeutics Inc
|
Director |
866.9 K |
- |
2020 |
AnaptysBio Inc
|
Independent Director |
183.2 K |
-10.3 % |
2019 |
AnaptysBio Inc
|
Independent Director |
204.2 K |
- |
2019 |
Y-Mabs Therapeutics Inc
|
Independent Director |
- |
- |